BridgeBio Pharma Ownership 2024 | Who Owns BridgeBio Pharma Now?
Institutional Ownership
93.12%
Insider Ownership
5.43%
Retail Ownership
1.45%
Institutional Holders
284.00
BridgeBio Pharma Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 16.56% | 23.60% | 31,060,971 | - | - | 786,774,395 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 13.39% | 2.45% | 25,120,991 | - | - | 636,314,702 | Jun 30, 2024 |
| VANGUARD GROUP INC | 7.49% | 0.01% | 14,054,748 | 832,622 | 6.30% | 356,006,766 | Jun 30, 2024 |
| BLACKROCK INC. | 6.64% | 0.01% | 12,448,272 | 1,981,337 | 18.93% | 315,314,728 | Jun 30, 2024 |
| AISLING CAPITAL MANAGEMENT LP | 3.23% | 66.52% | 6,068,125 | - | - | 153,705,606 | Jun 30, 2024 |
| STATE STREET CORP | 3.12% | 0.01% | 5,854,140 | 461,278 | 8.55% | 148,285,366,000 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 2.34% | 1.32% | 4,388,873 | -787,455 | -15.21% | 111,170,153 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 2.30% | 0.06% | 4,312,531 | 999,825 | 30.18% | 109,288,964 | Jun 30, 2024 |
| UBS GROUP AG | 2.06% | 0.02% | 3,863,500 | - | - | 97,862,455 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.94% | 4.30% | 3,632,604 | 217,000 | 6.35% | 92,013,859 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.75% | 0.01% | 3,290,409 | 427,564 | 14.93% | 83,361,581 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.41% | 0.08% | 2,648,957 | -283,472 | -9.67% | 67,098,081 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.31% | 0.02% | 2,452,404 | -391,895 | -13.78% | 62,119,393 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.23% | 0.01% | 2,298,039 | 672,280 | 41.35% | 58,209,328 | Jun 30, 2024 |
| CAPITAL RESEARCH GLOBAL INVESTORS | 1.18% | 0.01% | 2,212,085 | - | - | 56,032,113 | Jun 30, 2024 |
| SC US (TTGP), LTD. | 0.99% | 0.38% | 1,860,364 | - | - | 47,123,020 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.99% | 2.72% | 1,858,351 | -1,344,678 | -41.98% | 47,072,031 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.88% | 0.08% | 1,646,202 | 506,845 | 44.49% | 41,698,296 | Jun 30, 2024 |
| FMR LLC | 0.82% | 0.00% | 1,539,913 | -785,699 | -33.78% | 39,005,987 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.82% | 0.04% | 1,534,972 | 442,248 | 40.47% | 38,880,841 | Jun 30, 2024 |
BridgeBio Pharma's largest institutional shareholder is KOHLBERG KRAVIS ROBERTS & CO. L.P., holding 16.56% of the company's total share outstanding, currently valued at $786.77M. The top 10 institutional shareholders own together 59.07% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AISLING CAPITAL MANAGEMENT LP | 3.23% | 66.52% | 6,068,125 | - | - | 153,705,606 | Jun 30, 2024 |
| KOHLBERG KRAVIS ROBERTS & CO. L.P. | 16.56% | 23.60% | 31,060,971 | - | - | 786,774,395 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.12% | 7.02% | 219,837 | -133,670 | -37.81% | 5,568,471 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 0.43% | 6.06% | 800,000 | 210,470 | 35.70% | 20,264,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.67% | 6.05% | 1,264,570 | 714,766 | 130.00% | 32,031,558 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.94% | 4.30% | 3,632,604 | 217,000 | 6.35% | 92,013,859 | Jun 30, 2024 |
| M28 CAPITAL MANAGEMENT LP | 0.06% | 3.98% | 121,200 | - | - | 3,069,996 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.49% | 3.14% | 910,070 | 324,114 | 55.31% | 23,052,073 | Jun 30, 2024 |
| OCTAGON CAPITAL ADVISORS LP | 0.37% | 2.75% | 690,000 | - | - | 17,477,700 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.99% | 2.72% | 1,858,351 | -1,344,678 | -41.98% | 47,072,031 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.00% | 2.65% | 6,000 | -383,400 | -98.46% | 15,198,000 | Jun 30, 2024 |
| VIKING GLOBAL INVESTORS LP | 13.39% | 2.45% | 25,120,991 | - | - | 636,314,702 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.17% | 2.38% | 311,700 | 311,700 | 100.00% | 7,895,361 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.03% | 2.26% | 49,000 | 49,000 | 100.00% | 1,241,170 | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | 0.14% | 2.01% | 255,535 | 10,415 | 4.25% | 6,472,702 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.04% | 1.74% | 78,907 | 30,100 | 61.67% | 1,998,714 | Jun 30, 2024 |
| SOUTHPORT MANAGEMENT, L.L.C. | 0.01% | 1.70% | 15,000 | - | - | 379,950 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.18% | 1.47% | 332,013 | 50,000 | 17.73% | 8,409,889 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 2.34% | 1.32% | 4,388,873 | -787,455 | -15.21% | 111,170,153 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.07% | 1.11% | 140,000 | -35,000 | -20.00% | 3,546,200 | Jun 30, 2024 |
The largest BridgeBio Pharma shareholder by % of total assets is AISLING CAPITAL MANAGEMENT LP. The company owns 6.07M shares of BridgeBio Pharma (BBIO), representing 66.52% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 6.64% | 0.01% | 12,448,272 | 1,981,337 | 18.93% | 315,314,728 | Jun 30, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 0.58% | 1.06% | 1,089,492 | 1,089,492 | 100.00% | 27,596,832 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 2.30% | 0.06% | 4,312,531 | 999,825 | 30.18% | 109,288,964 | Jun 30, 2024 |
| NORGES BANK | 0.48% | 0.00% | 893,729 | 893,729 | 100.00% | 22,638,156 | Jun 30, 2024 |
| VANGUARD GROUP INC | 7.49% | 0.01% | 14,054,748 | 832,622 | 6.30% | 356,006,766 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.67% | 6.05% | 1,264,570 | 714,766 | 130.00% | 32,031,558 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 1.23% | 0.01% | 2,298,039 | 672,280 | 41.35% | 58,209,328 | Jun 30, 2024 |
| MAN GROUP PLC | 0.33% | 0.04% | 619,927 | 619,927 | 100.00% | 15,702,751 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.88% | 0.08% | 1,646,202 | 506,845 | 44.49% | 41,698,296 | Jun 30, 2024 |
| STATE STREET CORP | 3.12% | 0.01% | 5,854,140 | 461,278 | 8.55% | 148,285,366,000 | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 0.82% | 0.04% | 1,534,972 | 442,248 | 40.47% | 38,880,841 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.75% | 0.01% | 3,290,409 | 427,564 | 14.93% | 83,361,581 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.47% | 0.35% | 888,500 | 383,200 | 75.84% | 22,505,705 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.18% | 0.17% | 341,247 | 341,247 | 100.00% | 8,643,787 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.49% | 3.14% | 910,070 | 324,114 | 55.31% | 23,052,073 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.41% | 0.09% | 727,963 | 312,686 | 75.30% | 18,439,303 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.17% | 2.38% | 311,700 | 311,700 | 100.00% | 7,895,361 | Jun 30, 2024 |
| MELQART ASSET MANAGEMENT (UK) LTD | 0.16% | 0.65% | 307,911 | 307,911 | 100.00% | 7,799,386 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0.29% | 0.03% | 548,000 | 272,000 | 98.55% | 13,880,840 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.30% | 0.00% | 567,681 | 256,322 | 82.32% | 14,379,360 | Jun 30, 2024 |
As of Jun 30 2024, BridgeBio Pharma's largest institutional buyer is BLACKROCK INC.. The company purchased 1.98M stocks of BBIO, valued at $315.31M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LORD, ABBETT & CO. LLC | - | - | - | -2,804,394 | -100.00% | - | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.99% | 2.72% | 1,858,351 | -1,344,678 | -41.98% | 47,072,031 | Jun 30, 2024 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 0.15% | 0.00% | 276,369 | -1,168,748 | -80.88% | 7,001,000 | Jun 30, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 0.19% | 0.03% | 353,961 | -1,042,458 | -74.65% | 8,965,832 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 2.34% | 1.32% | 4,388,873 | -787,455 | -15.21% | 111,170,153 | Jun 30, 2024 |
| FMR LLC | 0.82% | 0.00% | 1,539,913 | -785,699 | -33.78% | 39,005,987 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.28% | 0.20% | 525,000 | -464,000 | -46.92% | 13,298,250 | Jun 30, 2024 |
| PORTMAN SQUARE CAPITAL LLP | 0.13% | 0.21% | 239,200 | -457,400 | -65.66% | 6,058,936 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 1.31% | 0.02% | 2,452,404 | -391,895 | -13.78% | 62,119,393 | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | 0.00% | 2.65% | 6,000 | -383,400 | -98.46% | 15,198,000 | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -380,000 | -100.00% | - | Jun 30, 2024 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 0.08% | 0.04% | 148,368 | -301,168 | -67.00% | 3,758,161 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.41% | 0.08% | 2,648,957 | -283,472 | -9.67% | 67,098,081 | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -223,468 | -100.00% | - | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 0.13% | 0.25% | 251,525 | -205,461 | -44.96% | 6,371,128 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 0.65% | 0.73% | 1,215,346 | -196,687 | -13.93% | 30,784,714 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.12% | 0.01% | 224,128 | -193,760 | -46.37% | 5,677,162 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.09% | 0.00% | 176,079 | -190,574 | -51.98% | 4,460,081 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.30% | 0.03% | 565,452 | -179,148 | -24.06% | 14,322,899 | Jun 30, 2024 |
As of Jun 30 2024, BridgeBio Pharma's biggest institutional seller is LORD, ABBETT & CO. LLC. The company sold -2.80M shares of BBIO, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PARADIGM BIOCAPITAL ADVISORS LP | 0.58% | 1.06% | 1,089,492 | 1,089,492 | 100.00% | 27,596,832 | Jun 30, 2024 |
| NORGES BANK | 0.48% | 0.00% | 893,729 | 893,729 | 100.00% | 22,638,156 | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | 0.18% | 0.17% | 341,247 | 341,247 | 100.00% | 8,643,787 | Jun 30, 2024 |
| MELQART ASSET MANAGEMENT (UK) LTD | 0.16% | 0.65% | 307,911 | 307,911 | 100.00% | 7,799,386 | Jun 30, 2024 |
| PORTMAN SQUARE CAPITAL LLP | 0.13% | 0.21% | 236,200 | 236,200 | 100.00% | 5,982,946 | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | 0.11% | 0.01% | 207,280 | 207,280 | 100.00% | 5,250,402 | Jun 30, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.09% | 0.10% | 167,839 | 167,839 | 100.00% | 4,251,362 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.05% | 0.00% | 81,232 | 81,232 | 100.00% | 2,057,000 | Jun 30, 2024 |
| ARISTEIA CAPITAL LLC | 0.04% | 0.04% | 76,222 | 76,222 | 100.00% | 1,930,703 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.01% | 75,625 | 75,625 | 100.00% | 1,915,581 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 68,896 | 68,896 | 100.00% | 1,743,794 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.03% | 2.26% | 49,000 | 49,000 | 100.00% | 1,241,170 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.02% | 0.00% | 38,946 | 38,946 | 100.00% | 986,502 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.02% | 0.00% | 35,000 | 35,000 | 100.00% | 4,375 | Jun 30, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 0.02% | 0.00% | 30,000 | 30,000 | 100.00% | 759,900 | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | 0.01% | 0.08% | 28,200 | 28,200 | 100.00% | 714,306 | Jun 30, 2024 |
| ALPINE GLOBAL MANAGEMENT, LLC | 0.01% | 0.12% | 26,634 | 26,634 | 100.00% | 674,639 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.01% | 0.04% | 21,421 | 21,421 | 100.00% | 543,000 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.01% | 0.00% | 14,890 | 14,890 | 100.00% | 377,000 | Jun 30, 2024 |
| TRANSCEND CAPITAL ADVISORS, LLC | 0.01% | 0.02% | 13,500 | 13,500 | 100.00% | 341,955 | Jun 30, 2024 |
| QUEST PARTNERS LLC | 0.01% | 0.05% | 13,324 | 13,324 | 100.00% | 337,497 | Jun 30, 2024 |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 0.01% | 0.00% | 13,185 | 13,185 | 100.00% | 333,976 | Jun 30, 2024 |
| DIAMETRIC CAPITAL, LP | 0.01% | 0.17% | 12,076 | 12,076 | 100.00% | 305,885 | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | 0.01% | 0.00% | 11,200 | 11,200 | 100.00% | 283,696 | Jun 30, 2024 |
| CORTON CAPITAL INC. | 0.01% | 0.15% | 11,029 | 11,029 | 100.00% | 279,365 | Jun 30, 2024 |
| LMR PARTNERS LLP | 0.01% | 0.00% | 10,898 | 10,898 | 100.00% | 276,046 | Jun 30, 2024 |
| CSS LLC/IL | 0.00% | 0.01% | 6,481 | 6,481 | 100.00% | 164,164 | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.00% | 0.00% | 3,905 | 3,905 | 100.00% | 98,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.02% | 3,700 | 3,700 | 100.00% | 93,721 | Jun 30, 2024 |
| ADVISORS ASSET MANAGEMENT, INC. | 0.00% | 0.00% | 2,931 | 2,931 | 100.00% | 74,242 | Jun 30, 2024 |
| CSS LLC/IL | 0.00% | 0.00% | 2,500 | 2,500 | 100.00% | 63,325 | Jun 30, 2024 |
| HEADLANDS TECHNOLOGIES LLC | 0.00% | 0.01% | 1,905 | 1,905 | 100.00% | 48,254 | Jun 30, 2024 |
| ELEQUIN SECURITIES, LLC | 0.00% | 0.00% | 314 | 314 | 100.00% | 7,954 | Jun 30, 2024 |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 0.00% | 0.00% | 200 | 200 | 100.00% | 5,066 | Jun 30, 2024 |
| LARSON FINANCIAL GROUP LLC | 0.00% | 0.00% | 183 | 183 | 100.00% | 4,635 | Jun 30, 2024 |
| SOUND INCOME STRATEGIES, LLC | 0.00% | 0.00% | 100 | 100 | 100.00% | 2,533 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | - | - | 90 | 90 | 100.00% | 2,280 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 68 | 68 | 100.00% | 1,722 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | 0.00% | 53 | 53 | 100.00% | 1,335 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | 0.00% | 51 | 51 | 100.00% | 1,292 | Jun 30, 2024 |
| PARALLEL ADVISORS, LLC | - | - | 36 | 36 | 100.00% | 912 | Jun 30, 2024 |
| PFG PRIVATE WEALTH MANAGEMENT, LLC | - | 0.00% | 11 | 11 | 100.00% | 279 | Jun 30, 2024 |
| CREEKMUR ASSET MANAGEMENT LLC | - | - | 3 | 3 | 100.00% | 76 | Jun 30, 2024 |
BridgeBio Pharma's largest new institutional shareholder by number of shares is PARADIGM BIOCAPITAL ADVISORS LP, purchased 1.09M shares, valued at $27.60M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| LORD, ABBETT & CO. LLC | - | - | - | -2,804,394 | -100.00% | - | Jun 30, 2024 |
| CANDRIAM S.C.A. | - | - | - | -380,000 | -100.00% | - | Jun 30, 2024 |
| AFFINITY ASSET ADVISORS, LLC | - | - | - | -250,000 | -100.00% | - | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -223,468 | -100.00% | - | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | - | - | - | -153,951 | -100.00% | - | Jun 30, 2024 |
| ABRDN PLC | - | - | - | -142,247 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -83,540 | -100.00% | - | Jun 30, 2024 |
| ZIMMER PARTNERS, LP | - | - | - | -73,200 | -100.00% | - | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -61,907 | -100.00% | - | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | - | - | - | -60,000 | -100.00% | - | Jun 30, 2024 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | - | - | - | -58,697 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -57,491 | -100.00% | - | Jun 30, 2024 |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | - | - | - | -43,416 | -100.00% | - | Jun 30, 2024 |
| EDGESTREAM PARTNERS, L.P. | - | - | - | -43,115 | -100.00% | - | Jun 30, 2024 |
| HAP TRADING, LLC | - | - | - | -38,039 | -100.00% | - | Jun 30, 2024 |
| VONTOBEL HOLDING LTD. | - | - | - | -30,216 | -100.00% | - | Jun 30, 2024 |
| BARCLAYS PLC | - | - | - | -30,000 | -100.00% | - | Jun 30, 2024 |
| TD ASSET MANAGEMENT INC | - | - | - | -29,074 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -22,164 | -100.00% | - | Jun 30, 2024 |
| CONCENTRIC CAPITAL STRATEGIES, LP | - | - | - | -21,329 | -100.00% | - | Jun 30, 2024 |
| CAPITAL FUND MANAGEMENT S.A. | - | - | - | -20,400 | -100.00% | - | Jun 30, 2024 |
| HRT FINANCIAL LP | - | - | - | -16,524 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -15,700 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -15,259 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | - | - | - | -12,400 | -100.00% | - | Jun 30, 2024 |
| CALAMOS ADVISORS LLC | - | - | - | -12,222 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -11,849 | -100.00% | - | Jun 30, 2024 |
| WALLEYE TRADING LLC | - | - | - | -10,800 | -100.00% | - | Jun 30, 2024 |
| MACKENZIE FINANCIAL CORP | - | - | - | -6,992 | -100.00% | - | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | - | - | - | -6,528 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -6,256 | -100.00% | - | Jun 30, 2024 |
| MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | - | - | - | -5,845 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -3,778 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -2,432 | -100.00% | - | Jun 30, 2024 |
| YHB INVESTMENT ADVISORS, INC. | - | - | - | -1,090 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | - | - | - | -103 | -100.00% | - | Jun 30, 2024 |
| MEEDER ASSET MANAGEMENT INC | - | - | - | -82 | -100.00% | - | Jun 30, 2024 |
| CONTINUUM ADVISORY, LLC | - | - | - | -34 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -33 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -22 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -3 | -100.00% | - | Jun 30, 2024 |
BridgeBio Pharma's largest sold out institutional shareholder by shares sold is LORD, ABBETT & CO. LLC, sold -2.80M shares, valued at -, as of undefined.
BridgeBio Pharma Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| LMP CAPITAL & INCOME FUND INC. | 6.58% | 1,960,000 | - | - | Feb 29, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 1.22% | 1,135,537 | 510,360 | 81.63% | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.91% | 2,165,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.91% | 1,805,000 | - | - | Jan 31, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.91% | 1,845,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.88% | 1,750,000 | 750,000 | 75.00% | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.87% | 2,070,000 | 860,000 | 71.07% | Jan 31, 2024 |
| Virtus Strategy Trust | 0.84% | 17,800,000 | - | - | Mar 28, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.75% | 1,520,000 | 640,000 | 72.73% | Jan 31, 2024 |
| Tema ETF Trust | 0.73% | 32,570 | 18,469 | 130.98% | Feb 29, 2024 |
| AGF Investments Trust | 0.62% | -11,737 | - | - | Mar 31, 2024 |
| Virtus Convertible & Income Fund | 0.58% | 2,860,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.57% | 2,150,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund II | 0.50% | 1,890,000 | 790,000 | 71.82% | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.48% | 2,390,000 | 1,000,000 | 71.94% | Jan 31, 2024 |
| Virtus Dividend, Interest & Premium Strategy Fund | 0.43% | 1,010,000 | - | - | Jan 31, 2024 |
| Virtus Equity & Convertible Income Fund | 0.42% | 840,000 | - | - | Jan 31, 2024 |
| Virtus Investment Trust | 0.41% | 14,175,000 | - | - | Mar 28, 2024 |
| Virtus Diversified Income & Convertible Fund | 0.36% | 740,000 | - | - | Jan 31, 2024 |
| Virtus Investment Trust | 0.35% | 12,175,000 | - | - | Mar 28, 2024 |
| Virtus Strategy Trust | 0.33% | 6,990,000 | -1,405,000 | -16.74% | Mar 28, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.31% | 1,451,626 | 1,449,431 | 66033.30% | Jan 31, 2024 |
| AB DISCOVERY GROWTH FUND, INC. | 0.30% | 454,069 | -23,747 | -4.97% | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.30% | 72,728 | 72,728 | - | Dec 31, 2023 |
| GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC | 0.27% | 215,000 | - | - | Dec 29, 2023 |
| Virtus Strategy Trust | 0.26% | 5,450,000 | - | - | Mar 28, 2024 |
| ELLSWORTH GROWTH & INCOME FUND LTD | 0.25% | 345,000 | - | - | Dec 29, 2023 |
| Virtus Convertible & Income Fund II | 0.24% | 915,000 | - | - | Jan 31, 2024 |
| Virtus Convertible & Income Fund | 0.24% | 1,165,000 | - | - | Jan 31, 2024 |
| BANCROFT FUND LTD | 0.23% | 320,000 | - | - | Dec 29, 2023 |
| TETON WESTWOOD FUNDS | 0.18% | 120,000 | - | - | Dec 29, 2023 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.18% | 568,500 | 114,400 | 25.19% | Mar 31, 2024 |
| BANCROFT FUND LTD | 0.17% | 235,000 | - | - | Dec 29, 2023 |
| Federated Hermes MDT Series | 0.15% | 375,087 | 87,419 | 30.39% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.15% | 76,322 | - | - | Mar 31, 2024 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.13% | 466,984 | - | - | Mar 31, 2024 |
| TEKLA HEALTHCARE INVESTORS | 0.12% | 103,392 | -104,198 | -50.19% | Mar 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.09% | 88,005 | 15,326 | 21.09% | Feb 29, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.08% | 38,855 | -38,548 | -49.80% | Mar 31, 2024 |
| PRIMECAP Odyssey Funds | 0.08% | 655,400 | 2,100 | 0.32% | Jan 31, 2024 |
| EntrepreneurShares Series Trust | 0.08% | 21,273 | - | - | Dec 31, 2023 |
| ALGER INSTITUTIONAL FUNDS | 0.08% | 20,438 | - | - | Jan 31, 2024 |
| ALGER PORTFOLIOS | 0.07% | 25,267 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS VARIABLE SERIES I | 0.07% | 24,077 | - | - | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.07% | 16,735 | 3,308 | 24.64% | Mar 31, 2024 |
| BlackRock Health Sciences Trust II | 0.06% | 169,445 | 102,850 | 154.44% | Mar 31, 2024 |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 0.06% | 42,974 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.06% | 11,101 | - | - | Mar 28, 2024 |
| ALGER FUNDS | 0.06% | 53,285 | - | - | Jan 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.05% | 1,255,396 | - | - | Jan 31, 2024 |
| AMERICAN CENTURY MUTUAL FUNDS, INC. | 0.04% | 423,936 | 72,796 | 20.73% | Jan 31, 2024 |
| LEGG MASON PARTNERS INVESTMENT TRUST | 0.04% | 2,040,000 | - | - | Mar 28, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.04% | 283,900 | -300 | -0.11% | Mar 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.04% | 4,277 | - | - | Mar 31, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.04% | 12,813 | -613 | -4.57% | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.04% | 51,933 | 3,282 | 6.75% | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 202,190 | -6,339 | -3.04% | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.03% | 20,319 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.03% | 114,188 | -25,232 | -18.10% | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.03% | 17,308 | -233 | -1.33% | Mar 31, 2024 |
| DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. | 0.03% | 61,761 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.03% | 11,704,490 | -1,569,270 | -11.82% | Mar 31, 2024 |
| Calvert Responsible Index Series, Inc. | 0.03% | 43,844 | - | - | Mar 31, 2024 |
| CALAMOS INVESTMENT TRUST/IL | 0.03% | 2,618,442 | - | - | Jan 31, 2024 |
| Gabelli 787 Fund, Inc. | 0.02% | 2,000 | - | - | Jan 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.02% | 11,790 | -4,890 | -29.32% | Mar 31, 2024 |
| AB CAP FUND, INC. | 0.02% | 788,441 | -88,578 | -10.10% | Jan 31, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.02% | 151,572 | - | - | Mar 31, 2024 |
| Northern Lights Variable Trust | 0.02% | 19,925 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Funds, Inc. | 0.02% | 216,106 | - | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.02% | 1,310,481 | 344,828 | 35.71% | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.02% | 59,276 | 961 | 1.65% | Feb 29, 2024 |
| Humankind Benefit Corp | 0.02% | 384 | -2 | -0.52% | Dec 31, 2023 |
| Bernstein Fund Inc | 0.01% | 128,680 | 53,070 | 70.19% | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 946,496 | -308,850 | -24.60% | Feb 29, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 3,248 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.01% | 118,800 | - | - | Jan 31, 2024 |
| AIM GROWTH SERIES (INVESCO GROWTH SERIES) | 0.01% | 388,238 | 38,099 | 10.88% | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.01% | 275,400 | - | - | Mar 31, 2024 |
| Vericimetry Funds | 0.01% | 960 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 70,289 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 401,044 | -10,165 | -2.47% | Jan 31, 2024 |
| HARBOR FUNDS | 0.01% | 218,480 | - | - | Jan 31, 2024 |
| MFS SERIES TRUST I | 0.01% | 176,816 | -68,408 | -27.90% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.01% | 109,796 | 75,843 | 223.38% | Mar 31, 2024 |
| IndexIQ ETF Trust | 0.01% | 19,618 | -1,342 | -6.40% | Jan 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.01% | 244,403 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.01% | 34,777 | 33,732 | 3227.94% | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND IV | 0.01% | 1,800,000 | - | - | Jan 31, 2024 |
| FIDELITY FINANCIAL TRUST | 0.01% | 133,500 | - | - | Feb 29, 2024 |
| VANGUARD EXPLORER FUND | 0.01% | 91,174 | -8,209 | -8.26% | Jan 31, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 45,117 | -9,617 | -17.57% | Aug 31, 2023 |
| John Hancock Exchange-Traded Fund Trust | 0.01% | 40,073 | -481 | -1.19% | Jan 31, 2024 |
| BARON SELECT FUNDS | 0.01% | 67,409 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.01% | 9,084 | -8,934 | -49.58% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.01% | 1,234,841 | 116,540 | 10.42% | Feb 29, 2024 |
| JANUS INVESTMENT FUND | 0.01% | 1,720,108 | - | - | Dec 31, 2023 |
| UBS FUNDS | 0.00% | 23,945 | - | - | Mar 31, 2024 |
| JOHCM Funds Trust | 0.00% | 50,000 | - | - | Mar 28, 2024 |
| JOHCM Funds Trust | 0.00% | 50,000 | - | - | Mar 28, 2024 |
BridgeBio Pharma's largest mutual fund holder by % of total assets is "LMP CAPITAL & INCOME FUND INC.", owning 1.96M shares, compromising 6.58% of its total assets.
BridgeBio Pharma Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 284 | 1.43% |
| 31 Mar, 24 | 280 | 3.32% |
| 31 Dec, 23 | 271 | 10.16% |
| 30 Sep, 23 | 246 | 0.82% |
| 30 Jun, 23 | 244 | -1.61% |
| 31 Mar, 23 | 248 | 37.78% |
| 31 Dec, 22 | 180 | -1.64% |
| 30 Sep, 22 | 183 | 5.78% |
| 30 Jun, 22 | 173 | -7.49% |
| 31 Mar, 22 | 187 | -18.70% |
| 31 Dec, 21 | 230 | 1.32% |
| 30 Sep, 21 | 227 | 4.13% |
| 30 Jun, 21 | 218 | - |
| 31 Mar, 21 | 218 | 24.57% |
| 31 Dec, 20 | 175 | 26.81% |
| 30 Sep, 20 | 138 | 9.52% |
| 30 Jun, 20 | 126 | 22.33% |
| 31 Mar, 20 | 103 | 19.77% |
| 31 Dec, 19 | 86 | 16.22% |
| 30 Sep, 19 | 74 | 21.31% |
| 30 Jun, 19 | 61 | - |
As of 30 Jun 24, 284 institutions are holding BridgeBio Pharma's shares, representing an increase of 1.43% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 174,683,428 | 2.52% |
| 31 Mar, 24 | 170,388,909 | 3.05% |
| 31 Dec, 23 | 165,339,966 | 3.06% |
| 30 Sep, 23 | 160,426,320 | 7.13% |
| 30 Jun, 23 | 149,742,658 | -1.65% |
| 31 Mar, 23 | 152,248,363 | 5.41% |
| 31 Dec, 22 | 144,431,519 | -0.50% |
| 30 Sep, 22 | 145,155,298 | 3.37% |
| 30 Jun, 22 | 140,421,824 | -1.99% |
| 31 Mar, 22 | 143,273,008 | 0.93% |
| 31 Dec, 21 | 141,958,377 | 1.42% |
| 30 Sep, 21 | 139,974,025 | -1.84% |
| 30 Jun, 21 | 142,600,163 | 1.13% |
| 31 Mar, 21 | 141,010,681 | 16.51% |
| 31 Dec, 20 | 121,028,366 | 2.75% |
| 30 Sep, 20 | 117,786,346 | 0.46% |
| 30 Jun, 20 | 117,243,319 | 3.90% |
| 31 Mar, 20 | 112,841,817 | 5.29% |
| 31 Dec, 19 | 107,169,624 | 3.77% |
| 30 Sep, 19 | 103,280,315 | 3.35% |
| 30 Jun, 19 | 99,928,072 | - |
BridgeBio Pharma (BBIO) has 174.68M shares outstanding as of 30 Jun 24, up 2.52% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 93.12% | 1.02% |
| 31 Mar, 24 | 95.35% | 0.92% |
| 31 Dec, 23 | 101.57% | 1.05% |
| 30 Sep, 23 | 98.24% | 1.13% |
| 30 Jun, 23 | 93.28% | 0.94% |
| 31 Mar, 23 | 99.74% | 1.04% |
| 31 Dec, 22 | 97.94% | 1.02% |
| 30 Sep, 22 | 98.12% | 1.07% |
| 30 Jun, 22 | 95.73% | 0.99% |
| 31 Mar, 22 | 98.21% | 1.02% |
| 31 Dec, 21 | 98.34% | 1.08% |
| 30 Sep, 21 | 95.44% | 1.01% |
| 30 Jun, 21 | 97.17% | 0.94% |
| 31 Mar, 21 | 101.72% | 0.98% |
| 31 Dec, 20 | 101.72% | 1.02% |
| 30 Sep, 20 | 99.68% | 0.99% |
| 30 Jun, 20 | 100.20% | 1.09% |
| 31 Mar, 20 | 95.79% | 1.16% |
| 31 Dec, 19 | 91.06% | 1.17% |
| 30 Sep, 19 | 88.22% | 0.76% |
| 30 Jun, 19 | 107.57% | - |
As of 30 Jun 24, BridgeBio Pharma is held by 93.12% institutional shareholders, representing a 1.02% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 152 | 11.76% |
| 31 Mar, 24 | 136 | -5.56% |
| 31 Dec, 23 | 144 | 19.01% |
| 30 Sep, 23 | 121 | 12.04% |
| 30 Jun, 23 | 108 | -24.48% |
| 31 Mar, 23 | 143 | 66.28% |
| 31 Dec, 22 | 86 | -10.42% |
| 30 Sep, 22 | 96 | 24.68% |
| 30 Jun, 22 | 77 | -12.50% |
| 31 Mar, 22 | 88 | -24.79% |
| 31 Dec, 21 | 117 | 1.74% |
| 30 Sep, 21 | 115 | 0.88% |
| 30 Jun, 21 | 114 | -27.39% |
| 31 Mar, 21 | 157 | 41.44% |
| 31 Dec, 20 | 111 | 81.97% |
| 30 Sep, 20 | 61 | -24.69% |
| 30 Jun, 20 | 81 | 19.12% |
| 31 Mar, 20 | 68 | 17.24% |
| 31 Dec, 19 | 58 | 16.00% |
| 30 Sep, 19 | 50 | -18.03% |
| 30 Jun, 19 | 61 | - |
152 institutional shareholders have increased their position in BBIO stock as of 30 Jun 24 compared to 136 in the previous quarter (a 11.76% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 72 | -15.29% |
| 31 Mar, 24 | 85 | 8.97% |
| 31 Dec, 23 | 78 | 1.30% |
| 30 Sep, 23 | 77 | 26.23% |
| 30 Jun, 23 | 61 | 3.39% |
| 31 Mar, 23 | 59 | -9.23% |
| 31 Dec, 22 | 65 | 27.45% |
| 30 Sep, 22 | 51 | -12.07% |
| 30 Jun, 22 | 58 | -1.69% |
| 31 Mar, 22 | 59 | -9.23% |
| 31 Dec, 21 | 65 | 4.84% |
| 30 Sep, 21 | 62 | - |
| 30 Jun, 21 | 62 | 77.14% |
| 31 Mar, 21 | 35 | -10.26% |
| 31 Dec, 20 | 39 | -26.42% |
| 30 Sep, 20 | 53 | 130.43% |
| 30 Jun, 20 | 23 | 35.29% |
| 31 Mar, 20 | 17 | 6.25% |
| 31 Dec, 19 | 16 | 6.67% |
| 30 Sep, 19 | 15 | - |
| 30 Jun, 19 | - | - |
72 institutional shareholders have reduced their position in BBIO stock as of 30 Jun 24 compared to 85 in the previous quarter (a -15.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 284 | 1.43% | 174,683,428 | 2.52% | 93.12% | 1.02% | 152 | 11.76% | 72 | -15.29% |
| 31 Mar, 24 | 280 | 3.32% | 170,388,909 | 3.05% | 95.35% | 0.92% | 136 | -5.56% | 85 | 8.97% |
| 31 Dec, 23 | 271 | 10.16% | 165,339,966 | 3.06% | 101.57% | 1.05% | 144 | 19.01% | 78 | 1.30% |
| 30 Sep, 23 | 246 | 0.82% | 160,426,320 | 7.13% | 98.24% | 1.13% | 121 | 12.04% | 77 | 26.23% |
| 30 Jun, 23 | 244 | -1.61% | 149,742,658 | -1.65% | 93.28% | 0.94% | 108 | -24.48% | 61 | 3.39% |
| 31 Mar, 23 | 248 | 37.78% | 152,248,363 | 5.41% | 99.74% | 1.04% | 143 | 66.28% | 59 | -9.23% |
| 31 Dec, 22 | 180 | -1.64% | 144,431,519 | -0.50% | 97.94% | 1.02% | 86 | -10.42% | 65 | 27.45% |
| 30 Sep, 22 | 183 | 5.78% | 145,155,298 | 3.37% | 98.12% | 1.07% | 96 | 24.68% | 51 | -12.07% |
| 30 Jun, 22 | 173 | -7.49% | 140,421,824 | -1.99% | 95.73% | 0.99% | 77 | -12.50% | 58 | -1.69% |
| 31 Mar, 22 | 187 | -18.70% | 143,273,008 | 0.93% | 98.21% | 1.02% | 88 | -24.79% | 59 | -9.23% |
| 31 Dec, 21 | 230 | 1.32% | 141,958,377 | 1.42% | 98.34% | 1.08% | 117 | 1.74% | 65 | 4.84% |
| 30 Sep, 21 | 227 | 4.13% | 139,974,025 | -1.84% | 95.44% | 1.01% | 115 | 0.88% | 62 | - |
| 30 Jun, 21 | 218 | - | 142,600,163 | 1.13% | 97.17% | 0.94% | 114 | -27.39% | 62 | 77.14% |
| 31 Mar, 21 | 218 | 24.57% | 141,010,681 | 16.51% | 101.72% | 0.98% | 157 | 41.44% | 35 | -10.26% |
| 31 Dec, 20 | 175 | 26.81% | 121,028,366 | 2.75% | 101.72% | 1.02% | 111 | 81.97% | 39 | -26.42% |
| 30 Sep, 20 | 138 | 9.52% | 117,786,346 | 0.46% | 99.68% | 0.99% | 61 | -24.69% | 53 | 130.43% |
| 30 Jun, 20 | 126 | 22.33% | 117,243,319 | 3.90% | 100.20% | 1.09% | 81 | 19.12% | 23 | 35.29% |
| 31 Mar, 20 | 103 | 19.77% | 112,841,817 | 5.29% | 95.79% | 1.16% | 68 | 17.24% | 17 | 6.25% |
| 31 Dec, 19 | 86 | 16.22% | 107,169,624 | 3.77% | 91.06% | 1.17% | 58 | 16.00% | 16 | 6.67% |
| 30 Sep, 19 | 74 | 21.31% | 103,280,315 | 3.35% | 88.22% | 0.76% | 50 | -18.03% | 15 | - |
| 30 Jun, 19 | 61 | - | 99,928,072 | - | 107.57% | - | 61 | - | - | - |
BridgeBio Pharma Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of BridgeBio Pharma's stock was made by Trimarchi Thomas on Jul 29 2024, selling - shares at - per share (valued at -).
BridgeBio Pharma Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 5 | 40.00% |
| Q2 2024 | 15 | 14 | 107.14% |
| Q1 2024 | 9 | 18 | 50.00% |
| Q4 2023 | 5 | 25 | 20.00% |
| Q3 2023 | 3 | 17 | 17.65% |
| Q2 2023 | 15 | 19 | 78.95% |
| Q1 2023 | 9 | 24 | 37.50% |
| Q4 2022 | 4 | 16 | 25.00% |
| Q3 2022 | 4 | 12 | 33.33% |
| Q2 2022 | 27 | 12 | 225.00% |
| Q1 2022 | 10 | 6 | 166.67% |
| Q4 2021 | 20 | 9 | 222.22% |
| Q3 2021 | 6 | 8 | 75.00% |
| Q2 2021 | 12 | 6 | 200.00% |
| Q1 2021 | 13 | 6 | 216.67% |
| Q4 2020 | 25 | 47 | 53.19% |
| Q3 2020 | 19 | 56 | 33.93% |
| Q2 2020 | 44 | 55 | 80.00% |
| Q1 2020 | 6 | 44 | 13.64% |
| Q4 2019 | 13 | 12 | 108.33% |
2 total buy trades, and 5 total sell trades (buy/sell ratio of 0.40%) were made by BridgeBio Pharma's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | 3 | - |
| Q4 2023 | - | 9 | - |
| Q3 2023 | - | 4 | - |
| Q2 2023 | - | 6 | - |
| Q1 2023 | - | 9 | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | 4 | - | - |
| Q4 2021 | 10 | 1 | 1000.00% |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 2 | 1 | 200.00% |
| Q4 2020 | - | 22 | - |
| Q3 2020 | - | 33 | - |
| Q2 2020 | - | 46 | - |
| Q1 2020 | - | 40 | - |
| Q4 2019 | - | 10 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of BridgeBio Pharma's stocks.
BridgeBio Pharma Peer Ownership
| Ticker | Company |
|---|---|
| XFOR | X4 Pharmaceuticals, Inc. |
| PTCT | PTC Therapeutics, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| CERE | Cerevel Therapeutics Holdings, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| KRYS | Krystal Biotech, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| MDGL | Madrigal Pharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
BBIO Ownership FAQ
Who Owns BridgeBio Pharma?
BridgeBio Pharma is owned by institutional shareholders (93.12%), insiders (5.43%), and public (1.45%). The largest institutional shareholder of BridgeBio Pharma is KOHLBERG KRAVIS ROBERTS & CO. L.P. (16.56% of total shares) and the top mutual fund owner is LMP CAPITAL & INCOME FUND INC. (6.58% of total shares).
Who are the major institutional shareholders of BridgeBio Pharma?
BridgeBio Pharma's major institutional shareholders are KOHLBERG KRAVIS ROBERTS & CO. L.P., VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, BLACKROCK INC., and AISLING CAPITAL MANAGEMENT LP. The top five shareholders own together 47.31% of the company's share outstanding.
How many BridgeBio Pharma shareholders are there?
As of Jun 2024, there are 284 institutional shareholders of BridgeBio Pharma.
What percentage of BridgeBio Pharma is owned by KOHLBERG KRAVIS ROBERTS & CO. L.P?
KOHLBERG KRAVIS ROBERTS & CO. L.P owns 31.06M shares of BridgeBio Pharma, representing 16.56% of the company's total shares outstanding, valued at $786.77M (as of Jun 2024).
What percentage of BridgeBio Pharma is owned by VIKING GLOBAL INVESTORS LP?
As of Jun 2024, VIKING GLOBAL INVESTORS LP holds 25.12M shares of BridgeBio Pharma (BBIO), compromising 13.39% of the company, valued at $636.31M.
What percentage of BridgeBio Pharma is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of BridgeBio Pharma. The company owns 14.05M of the company's shares outstanding (worth $356.01M).